Hypoxia-Inducible Factor-1α G Polymorphism and the Risk of Cancer: A Meta-Analysis

Abstract

Aims and background

Hypoxia-inducible factor-1α (HIF-1α), a transcription factor, is associated with the initiation and progression of malignant tumors. HIF-1α G (A588T) polymorphism has been shown to lead to genetic susceptibility to malignant tumors but results have been controversial.

Methods and study design

We carried out a meta-analysis on 21 eligible case-control studies with a total of 3892 cases and 6915 healthy controls to analyze the data with respect to the associations between HIF-1α G polymorphism and the risk of cancer. The overall odds ratio (OR) with a 95% confidence interval (CI) were used to assess the association.

Results

A statistically significant association between the HIF-1α GA/AA genotype and cancer risk was found in the meta-analysis (OR, 1.79; 95% CI, 1.12–2.86; P_{heterogeneity} <0.00001). In the subgroup analysis by ethnicity, significantly increased cancer risks were revealed among European and East Asian populations for the GA/AA genotype compared to the GG genotype (OR, 3.54; 95% CI, 1.34–9.30; P_{heterogeneity} = 0.005; OR, 1.84; 95% CI, 1.06–3.17; P_{heterogeneity} = 0.001, respectively). In the subgroup analysis by different tumor types, GA/AA genotype markedly increased the risk of oral cancer and digestive system cancers (OR, 3.15; 95% CI, 1.05–9.47; P_{heterogeneity} = 0.004; OR, 2.20; 95% CI, 1.12–4.34; P_{heterogeneity} = 0.002; respectively). Moreover, no publication bias was shown, which was assessed by Begg's funnel plots.

Conclusions

Our findings revealed that GA/AA genotype might be related to increased risks of oral cancer and digestive system cancers. Moreover, HIF-1α G polymorphism might contribute to high susceptibility to malignant tumors, especially in European and East Asian populations.